Xtant Medical to Attend the CG 45th Annual Growth Conference

Rhea-AI Summary

Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has announced its participation in the upcoming CG 45th Annual Growth Conference.

CEO Sean Browne and CFO Scott Neils will represent the company at the event, which is scheduled for August 12, 2025, at 3:30 PM ET in Boston, MA. The format will include both one-on-one meetings and a presentation. Interested parties can access the webcast through the provided link.

News Market Reaction

+9.75%

3 alerts

+9.75% News Effect

+5.4% Peak Tracked

+$8M Valuation Impact

$93M Market Cap

0.4x Rel. Volume

On the day this news was published, XTNT gained 9.75%, reflecting a notable positive market reaction. Argus tracked a peak move of +5.4% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $8M to the company's valuation, bringing the market cap to $93M at that time.

Data tracked by StockTitan Argus on the day of publication.

BELGRADE, Mont., Aug. 6, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that Sean Browne, CEO and Scott Neils, CFO will be attending the following upcoming conference:

Event: CG 45th Annual Growth Conference
Date: August 12, 2025 at 3:30pm ET
Location: Boston, MA
Format: 1x1 Meetings & Presentation

For more information, please visit:
https://wsw.com/webcast/canaccord108/xtnt/2576418 

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-attend-the-cg-45th-annual-growth-conference-302523503.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

When is Xtant Medical (XTNT) presenting at the CG 45th Annual Growth Conference?

Xtant Medical will present on August 12, 2025 at 3:30 PM ET in Boston, MA.

Who will represent Xtant Medical at the CG Growth Conference?

CEO Sean Browne and CFO Scott Neils will represent Xtant Medical at the conference.

What is the format of Xtant Medical's participation at the CG Conference?

The format includes one-on-one meetings and a presentation.

How can investors access Xtant Medical's presentation at the CG Conference?

Investors can access the webcast through the link: https://wsw.com/webcast/canaccord108/xtnt/2576418

What is Xtant Medical's (XTNT) main business focus?

Xtant Medical is a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders.